You searched for "retraction"
Adjuvant radiotherapy for T4N0 laryngeal cancers treated with laryngectomy
A total laryngectomy remains the gold standard for the initial treatment of advanced (T4) squamous cell carcinomas of the larynx without evidence of distant disease. Adjuvant radiotherapy (RT) is also recommended for such cancers. In the absence of other adverse...New innovative Head & Neck Ultrasound Course at St George’s Hospital London
The St George’s Emergency Head & Neck Ultrasound Course (18 September 2025) Emergency head and neck ultrasound is an increasingly vital diagnostic tool in acute care settings. It offers rapid, non-invasive assessment of critical structures including the airway, neck vessels,...BTA Plug’em campaign – teaching young people how to enjoy live music safely
In today’s world of ever-increasing sound levels, the Plug’em campaign, run by the British Tinnitus Association (BTA), is highlighting the issue of tinnitus caused by loud music in people aged 16-25 years old. The purpose of the campaign is to...
Operating room with a live electrical wire!
Education in healthcare is essential for enhancing patient safety, improving informed consent and enabling personal and professional development. Surgical training often focuses on common complications and the consent process for these potential adverse outcomes. But what about education on less...
Imagine a future without hearing loss
This article reflects on both the past 20 years and the next 20 years of research and service provision for children who are deaf or hard of hearing. The authors describe how universal newborn hearing screens have had a dramatic...
Allergic rhinitis, the usual suspects
Allergic rhinitis (AR) is characterised by allergen binding to IgE on mast cells and basophils and subsequent histamine, prostaglandine D2 (PGD2) and cysteinyl leukotrienes (cysLTs) release causing early-phase response. This is followed by late-phase response mediated by eosinophils. Other cells,...
Is Dymista® useful for paediatric allergic rhinitis?
Allergic rhinitis (AR) affects up to 14.6% of the paediatric population. Whilst a recent Cochrane review has considered the evidence for intranasal corticosteroids as `weak and unreliable’ in paediatric AR, this product is a novel formulation combining Fluticasone and Azelastine...
